MGX
Metagenomi Therapeutics, Inc.
-0.00 (-0.01%)1.15USD53.5K成交股數43.4M市值–本益比(近四季)1.9股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 2 · 23K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 5K · 3 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 23K · 14K |
| 近 180 天 淨額 | 9K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 | 09-11 | Reid Laurence | Director | P 公開市場買進 | 117 | 1.18 | 138.06 | 20.0K | SEC |
| 2026-09-09 | 09-11 | Reid Laurence | Director | P 公開市場買進 | 19.9K | 1.17 | 23K | 19.9K | SEC |
| 2026-09-08 | 09-10 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.9K | 1.16 | 2K | 207K | SEC |
| 2026-09-08 | 09-10 | Irish Jian | See Remarks | S 公開市場賣出 | 2.1K | 1.16 | 2K | 375K | SEC |
| 2026-09-08 | 09-10 | Wein Matthew | See Remarks | S 公開市場賣出 | 358 | 1.16 | 414.71 | 126K | SEC |
| 2026-06-05 | 06-10 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 2.9K | 1.30 | 4K | 208K | SEC |
| 2026-06-05 | 06-10 | Wein Matthew | See Remarks | S 公開市場賣出 | 558 | 1.30 | 725.40 | 126K | SEC |
| 2026-06-05 | 06-10 | Irish Jian | See Remarks | S 公開市場賣出 | 3.7K | 1.30 | 5K | 378K | SEC |
| 2026-04-01 | 04-03 | Wein Matthew | See Remarks | A 獲配股票 | 11.0K | – | – | 126K | SEC |
| 2026-04-01 | 04-03 | Irish Jian | See Remarks | A 獲配股票 | 46.0K | – | – | 380K | SEC |
| 2026-04-01 | 04-03 | Wapnick Pamela | Chief Financial Officer | A 獲配股票 | 24.0K | – | – | 211K | SEC |
| 2026-03-05 | 03-09 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.6K | 1.60 | 3K | 187K | SEC |
| 2026-03-05 | 03-09 | Irish Jian | Chief Executive Officer | S 公開市場賣出 | 1.6K | 1.60 | 3K | 334K | SEC |
| 2026-03-05 | 03-09 | Wein Matthew | See Remarks | S 公開市場賣出 | 482 | 1.60 | 771.20 | 115K | SEC |
| 2025-12-05 | 03-09 | Irish Jian | Chief Executive Officer | G 贈與 | 228K | – | – | 335K | SEC |
| 2025-12-05 | 12-08 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.6K | 1.77 | 3K | 189K | SEC |
| 2025-12-05 | 12-08 | Irish Jian | Chief Executive Officer | S 公開市場賣出 | 1.6K | 1.77 | 3K | 564K | SEC |
| 2025-12-05 | 12-08 | Wein Matthew | See Remarks | S 公開市場賣出 | 199 | 1.77 | 352.23 | 115K | SEC |
| 2025-12-05 | 12-08 | Thomas Brian C. | Director | S 公開市場賣出 | 3.8K | 1.77 | 7K | 2.5M | SEC |
| 2025-12-01 | 12-01 | Irish Jian | Chief Executive Officer | A 獲配股票 | 211K | 1.60 | 338K | 565K | SEC |
| 2025-12-01 | 12-01 | Wein Matthew | See Remarks | A 獲配股票 | 96.0K | 1.60 | 154K | 115K | SEC |
| 2025-12-01 | 12-01 | Wapnick Pamela | Chief Financial Officer | A 獲配股票 | 120K | 1.60 | 192K | 191K | SEC |
| 2025-12-01 | 12-01 | Irish Jian | Chief Executive Officer | A 獲配股票 | 37.5K | 1.60 | 60K | 354K | SEC |
| 2025-09-05 | 12-01 | Wein Matthew | See Remarks | S 公開市場賣出 | 199 | 1.81 | 360.19 | 19.2K | SEC |
| 2025-09-05 | 12-01 | Irish Jian | Chief Executive Officer | S 公開市場賣出 | 1.6K | 1.81 | 3K | 317K | SEC |
| 2025-09-05 | 12-01 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.6K | 1.81 | 3K | 70.5K | SEC |
| 2025-09-05 | 12-01 | Thomas Brian C. | Director | S 公開市場賣出 | 2.7K | 1.81 | 5K | 2.5M | SEC |
| 2025-06-06 | 06-09 | Irish Jian | See Remarks | S 公開市場賣出 | 6.4K | 1.75 | 11K | 316K | SEC |
| 2025-06-06 | 06-09 | Thomas Brian C. | Chief Executive Officer | S 公開市場賣出 | 10.8K | 1.75 | 19K | 2.5M | SEC |
| 2025-06-06 | 06-09 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.6K | 1.75 | 3K | 72.1K | SEC |
| 2025-06-06 | 06-09 | Noonberg Sarah B. | Chief Medical Officer | S 公開市場賣出 | 5.2K | 1.75 | 9K | 109K | SEC |
| 2025-06-06 | 06-09 | Wein Matthew | See Remarks | S 公開市場賣出 | 199 | 1.75 | 348.25 | 16.7K | SEC |
| 2025-04-01 | 04-03 | Irish Jian | See Remarks | A 獲配股票 | 23.0K | – | – | 322K | SEC |
| 2025-04-01 | 04-03 | Noonberg Sarah B. | Chief Medical Officer | A 獲配股票 | 14.0K | – | – | 114K | SEC |
| 2025-04-01 | 04-03 | Wein Matthew | See Remarks | A 獲配股票 | 3.6K | – | – | 13.1K | SEC |
| 2025-04-01 | 04-03 | Wein Matthew | See Remarks | A 獲配股票 | 3.8K | – | – | 16.9K | SEC |
| 2025-04-01 | 04-03 | Thomas Brian C. | Chief Executive Officer | A 獲配股票 | 32.0K | – | – | 2.5M | SEC |
| 2025-04-01 | 04-03 | Wapnick Pamela | Chief Financial Officer | A 獲配股票 | 14.0K | – | – | 73.7K | SEC |
| 2025-03-05 | 03-07 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.8K | 1.87 | 3K | 59.7K | SEC |
| 2025-03-05 | 03-07 | Wein Matthew | See Remarks | S 公開市場賣出 | 930 | 1.87 | 2K | 9.5K | SEC |
| 2024-12-05 | 12-06 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 1.6K | 1.86 | 3K | 61.5K | SEC |
| 2024-09-05 | 09-06 | Wapnick Pamela | Chief Financial Officer | S 公開市場賣出 | 6.3K | 2.88 | 18K | 63.1K | SEC |
| 2024-04-01 | 04-03 | Thomas Brian C. | Chief Executive Officer | A 獲配股票 | 119K | – | – | 2.5M | SEC |
| 2024-04-01 | 04-03 | Delaney Simren | See Remarks | A 獲配股票 | 6.9K | – | – | 93.9K | SEC |
| 2024-04-01 | 04-03 | Harnest Simon | See Remarks | A 獲配股票 | 11.6K | – | – | 123K | SEC |
| 2024-04-01 | 04-03 | Noonberg Sarah B. | Chief Medical Officer | A 獲配股票 | 57.8K | – | – | 100K | SEC |
| 2024-04-01 | 04-03 | Wapnick Pamela | Chief Financial Officer | A 獲配股票 | 69.3K | – | – | 69.3K | SEC |
| 2024-04-01 | 04-03 | Wein Matthew | See Remarks | A 獲配股票 | 10.4K | – | – | 10.4K | SEC |
| 2024-04-01 | 04-03 | Borges Luis | Chief Scientific Officer | A 獲配股票 | 69.3K | – | – | 69.3K | SEC |
| 2024-04-01 | 04-03 | Irish Jian | See Remarks | A 獲配股票 | 70.5K | – | – | 299K | SEC |
| 2024-02-13 | 02-15 | BAYER AKTIENGESELLSCHAFT | TenPercentOwner | C 轉換 | 1.2M | – | – | 3.0M | SEC |
| 2024-02-13 | 02-15 | Novo Holdings A/S | TenPercentOwner | C 轉換 | 839K | – | – | 939K | SEC |
| 2024-02-13 | 02-15 | Novo Holdings A/S | TenPercentOwner | P 公開市場買進 | 800K | 15.00 | 12.0M | 1.7M | SEC |
| 2024-02-13 | 02-15 | BAYER AKTIENGESELLSCHAFT | TenPercentOwner | C 轉換 | 1.8M | – | – | 1.8M | SEC |
| 2024-02-13 | 02-15 | Bayer US Holding LP | TenPercentOwner | C 轉換 | 1.2M | – | – | 3.0M | SEC |
| 2024-02-13 | 02-15 | Bayer US Holding LP | TenPercentOwner | C 轉換 | 590K | – | – | 3.5M | SEC |
| 2024-02-13 | 02-15 | Bayer US Holding LP | TenPercentOwner | C 轉換 | 510K | – | – | 4.1M | SEC |
| 2024-02-13 | 02-15 | BAYER AKTIENGESELLSCHAFT | TenPercentOwner | C 轉換 | 590K | – | – | 3.5M | SEC |
| 2024-02-13 | 02-15 | BAYER AKTIENGESELLSCHAFT | TenPercentOwner | C 轉換 | 510K | – | – | 4.1M | SEC |
| 2024-02-13 | 02-15 | BAYER HEALTHCARE LLC | TenPercentOwner | C 轉換 | 1.8M | – | – | 1.8M | SEC |
| 2024-02-13 | 02-15 | BAYER HEALTHCARE LLC | TenPercentOwner | C 轉換 | 1.2M | – | – | 3.0M | SEC |
| 2024-02-13 | 02-15 | BAYER HEALTHCARE LLC | TenPercentOwner | C 轉換 | 590K | – | – | 3.5M | SEC |
| 2024-02-13 | 02-15 | BAYER HEALTHCARE LLC | TenPercentOwner | C 轉換 | 510K | – | – | 4.1M | SEC |
| 2024-02-13 | 02-15 | Bayer World Investments B.V. | TenPercentOwner | C 轉換 | 1.8M | – | – | 1.8M | SEC |
| 2024-02-13 | 02-15 | Bayer World Investments B.V. | TenPercentOwner | C 轉換 | 1.2M | – | – | 3.0M | SEC |
| 2024-02-13 | 02-15 | Bayer World Investments B.V. | TenPercentOwner | C 轉換 | 590K | – | – | 3.5M | SEC |
| 2024-02-13 | 02-15 | Bayer World Investments B.V. | TenPercentOwner | C 轉換 | 510K | – | – | 4.1M | SEC |
| 2024-02-13 | 02-15 | Bayer US Holding LP | TenPercentOwner | C 轉換 | 1.8M | – | – | 1.8M | SEC |
| 2024-02-13 | 02-14 | Bernales Sebastian | Director | C 轉換 | 513K | – | – | 770K | SEC |
| 2024-02-13 | 02-14 | Bernales Sebastian | Director | C 轉換 | 1.9M | – | – | 1.9M | SEC |
| 2024-02-09 | 02-15 | Novo Holdings A/S | TenPercentOwner | P 公開市場買進 | 100K | 10.25 | 1.0M | 100K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | 1.3M | +19.8K (+2%) | 加碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 742K | 883K | −45.5K (-6%) | 減碼 |
| Catalio Capital Management, LP | 529K | 630K | 不變 | 持平 |
| Peapod Lane Capital LLC | 525K | 625K | +8.3K (+2%) | 加碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 514K | 611K | +16.9K (+3%) | 加碼 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 400K | 476K | +4.5K (+1%) | 加碼 |
| WELLS FARGO & COMPANY/MN | 380K | 452K | +177K (+88%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 289K | 344K | −69.5K (-19%) | 減碼 |
| PURA VIDA INVESTMENTS, LLC | 264K | 315K | 不變 | 持平 |
| BlackRock, Inc. | 258K | 307K | +27.5K (+12%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 171K | 204K | +1.1K (+1%) | 加碼 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 160K | 190K | −222K (-58%) | 減碼 |
| STATE STREET CORP | 120K | 143K | −577 (-0%) | 減碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 114K | 136K | −56.1K (-33%) | 減碼 |
| Man Group plc | 109K | 130K | +30.5K (+39%) | 加碼 |
| Resolute Advisors LLC | 89.9K | 107K | 不變 | 持平 |
| Marquette Asset Management, LLC | 72.1K | 86K | 新進 | 新進 |
| NORTHERN TRUST CORP | 68.9K | 82K | −6.2K (-8%) | 減碼 |
| RBF Capital, LLC | 64.0K | 76K | 不變 | 持平 |
| XTX Topco Ltd | 55.7K | 66K | +15.1K (+37%) | 加碼 |
| BBR PARTNERS, LLC | 53.4K | 64K | 不變 | 持平 |
| JANE STREET GROUP, LLC | 38.4K | 46K | −113K (-75%) | 減碼 |
| Fortitude Advisory Group L.L.C. | 37.2K | 44K | 不變 | 持平 |
| 城堡 CITADEL ADVISORS LLC | 17.9K | 21K | +858 (+5%) | 加碼 |
| Qube Research & Technologies Ltd | 16.9K | 20K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 43 -5 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 4 / 9 / 11 / 12 |
| 機構合計持股 · 佔流通股 | 6.3M · 16.6% |
| 合計季末市值 | 7.5M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.4M |
|---|---|
| 與上期比 | -1.2% |
| 佔流通股數 | 3.80% |
| 日均成交量 | 136K |
| 回補天數 | 10.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.4M | -1.2% | 3.80% | 136K | 10.6 |
| 2026-08-14 | 1.5M | -2.7% | 3.85% | 132K | 11.0 |
| 2026-07-31 | 1.5M | -3.2% | 3.95% | 148K | 10.1 |
| 2026-07-15 | 1.5M | -8.4% | 4.09% | 238K | 6.5 |
| 2026-06-30 | 1.7M | -4.1% | 4.46% | 145K | 11.6 |
| 2026-06-15 | 1.8M | -4.1% | 4.65% | 154K | 11.4 |
| 2026-05-29 | 1.8M | +1.3% | 4.85% | 199K | 9.2 |
| 2026-05-15 | 1.8M | +1.1% | 4.78% | 179K | 10.1 |
| 2026-04-30 | 1.8M | -4.4% | 4.73% | 181K | 9.9 |
| 2026-04-15 | 1.9M | -13.7% | 4.95% | 171K | 10.9 |
| 2026-03-31 | 2.2M | +8.2% | 5.74% | 214K | 10.2 |
| 2026-03-13 | 2.0M | +3.7% | 5.30% | 324K | 6.2 |
| 2026-02-27 | 1.9M | -2.6% | 5.11% | 160K | 12.1 |
| 2026-02-13 | 2.0M | -18.2% | 5.25% | 307K | 6.5 |
| 2026-01-30 | 2.4M | +2.7% | 6.41% | 250K | 9.7 |
| 2026-01-15 | 2.4M | +6.8% | 6.24% | 274K | 8.6 |
| 2025-12-31 | 2.2M | +8.0% | 5.85% | 359K | 6.2 |
| 2025-12-15 | 2.0M | +27.1% | 5.41% | 391K | 5.2 |
| 2025-11-28 | 1.6M | +31.1% | 4.26% | 361K | 4.5 |
| 2025-11-14 | 1.2M | -12.4% | 3.25% | 493K | 2.5 |
| 2025-10-31 | 1.4M | -13.0% | 3.71% | 991K | 1.4 |
| 2025-10-15 | 1.6M | +8.1% | 4.27% | 887K | 1.8 |
| 2025-09-30 | 1.5M | +36.2% | 3.95% | 819K | 1.8 |
| 2025-09-15 | 1.1M | -23.2% | 2.90% | 158K | 7.0 |
| 2025-08-29 | 1.4M | -4.8% | 3.77% | 187K | 7.6 |
| 2025-08-15 | 1.5M | +7.6% | 3.96% | 405K | 3.7 |